Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.779174
Title: Pharmacological and second messenger-mediated modulation of heterologously expressed and neuronal calcium-dependent potassium currents
Author: Howe, Timothy
ISNI:       0000 0004 7964 8749
Awarding Body: UCL (University College London)
Current Institution: University College London (University of London)
Date of Award: 2019
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Please try the link below.
Access from Institution:
Abstract:
The modulation of calcium-activated and calcium and voltage-dependent potassium channels, by drugs and second messengers, was investigated using the whole cell patch clamp technique in hippocampal slices, primary neuronal cultures, and transiently transfected HEK293 cells. The voltage and Ca2+-sensitive BK channel has emerged as a potential therapeutic target in conditions including multiple sclerosis and Fragile X syndrome. The Selwood lab have developed a compound, VSN-16R, that can rescue functions in mouse models of these diseases, and preliminary evidence suggested VSN-16R might act as a BK channel activator. In the first part of the project I tested VSN-16R on heterologously expressed BK channels formed from α-subunit homomultimers or from coexpression of the alpha subunit with β subunits, and determined that VSN-16R does not act as an activator of these channels. Additionally, I characterised for the first time the effects of the BK activator NS19504 on heterologously expressed channels incorporating beta subunits, and assessed the effects of VSN-16R in the presence of intracellular reducing agents glutathione and dithiothreitol, and under conditions of oxidative stress produced by extracellular application of H2O2. In the second part of my thesis I aimed to discover the location of discrete subcellular signalling domains involved in the regulation of the slow afterhyperpolarising current (sIAHP) in hippocampal pyramidal neurons by monoaminergic transmitters. Various monoamines, including noradrenaline, converge on a pathway involving the activation of PKA by elevated cAMP levels, which leads to the inhibition of the sIAHP by an unknown mechanism. The results of my experiments provide evidence of subcellular spatial variation in the degree of sIAHP inhibition in response to focal application of the βadrenergic agonist isoproterenol, and to localised uncaging of cAMP on the inhibition of the sIAHP.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.779174  DOI: Not available
Share: